0001567619-21-009092.txt : 20210505 0001567619-21-009092.hdr.sgml : 20210505 20210505160202 ACCESSION NUMBER: 0001567619-21-009092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210503 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GHALIE RICHARD G CENTRAL INDEX KEY: 0001156208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 21893110 MAIL ADDRESS: STREET 1: C/O FAVRILLE, INC STREET 2: 10445 PACIFIC CENTER COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc1.xml FORM 4 X0306 4 2021-05-03 0 0001262104 MEI Pharma, Inc. MEIP 0001156208 GHALIE RICHARD G C/O MEI PHARMA, INC., 11455 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 3.55 2021-05-03 4 A 0 75000 0 A 2031-05-03 Common Stock 75000 75000 D Stock Option (Right to Buy) 1.21 2026-03-07 Common Stock 130000 130000 D Stock Option (Right to Buy) 1.38 2026-07-14 Common Stock 25000 155000 D Stock Option (Right to Buy) 2.88 2027-07-07 Common Stock 65000 220000 D Stock Option (Right to Buy) 4.28 2028-07-12 Common Stock 130000 350000 D Stock Option (Right to Buy) 2.52 2029-07-01 Common Stock 150000 500000 D Stock Option (Right to Buy) 3.49 2030-07-02 Common Stock 150000 650000 D 1/4th of shares vest one-year from 5/03/2021, with the remaining balance of shares vesting in 36 equal amounts over three years. All options are currently exercisable. 1/4th of shares vest one-year from July 7, 2017, with the remaining balance of shares vesting in 36 equal amounts over three years. 1/4th of shares vest one-year from July 12, 2018, with the remaining balance of shares vesting in 36 equal amounts over three years. 1/4th of shares vest one-year from July 1, 2019, with the remaining balance of shares vesting in 36 equal amounts over three years. 1/4th of shares vest one-year from July 2, 2020, with the remaining balance of shares vesting in 36 equal amounts over three years. /s/ Richard Ghalie MD 2021-05-05